INTRODUCTION
Lymphedema is a malady of the lymphatic system due to low output failure resulting in abnormal collection of protein-rich fluid in the interstitium. Lymphedema incidence is varied around the world. In developed countries, the bulk of the cases are due to cancer and obesity.
Worldwide, filariasis in endemic areas is the most common cause. The incidence of primary lymphedema is 1 of 10,000 general populations, with females accounting to 70-80% of cases. 1 tarda. Lymphatic drainage is impeded by an acquired blockade or by disruption of the local lymphatic channels, in secondary lymphedema. This may be due to filariasis, malignancy, recurrent attacks of lymphangitis, obesity or surgery. Primarily lower extremity is involved (80%) but upper extremities, trunk, face and genitalia can also be affected.
Because of increased protein content in extravascular tissue, there is subsequent retention of water with resultant soft tissue swelling. Ensuing fibroblast proliferation and fluid organization results in non-pitting swelling of the affected region. Recurrent episodes of cellulitis, lymphangitis, fissuring, ulcerations, and verrucous changes occur with bacterial or fungal infections due to suppression of local immunologic surveillance. This has severe detrimental effects on patient's daily activities. Fissuring causes leakage of lymph onto the surface of the skin (lymphorrhea). Also, recurrent episodes of ulceration and healing may stimulate keratinocyte proliferation which may result in neoplastic transformation. Chronic lymphedema patients have a 10% risk of developing lymphangiosarcoma. Squamous cell carcinoma, Kaposi's sarcoma and malignant fibrous histiocytoma are also known to occur. 2 The rationale of lymphedema therapy is palliative with intent to prevent disease progression rather than cure. Current treatment strategies are disappointing and are difficult to reproduce the desired results. Patients have to endure a lifelong physical therapy with manual lymphatic drainage and uncomfortable elastic garments with high degree of non-compliance. With the current knowledge of pathophysiology and progress in the field of molecular biology, which facilitates us to understand lymphostasis consequence in the form of morphologic and functional alterations in tissues, a rational therapy needs to be formulated. Also there is a need for implementation of effective preventive treatment strategies for susceptible patients.
Early surgical procedures aimed to reduce limb volume by debulking resection approach. The present advent of microsurgery has use of lymphatic-venous anastomoses which is being performed in select few centers. 3 Though ideologically convincing the success of it has not been demonstrated equivocally. Hence, both the physician and patient opt for conservative treatments, notably in early stages of lymphedema. 4 Complex decongestive physiotherapy (CDP) constituting of manual lymph drainage (MLD), skin care, compression, and remedial exercises to maintain lymphatic flow has become a common treatment for lymphedema worldwide. 5 CDP aims at mobilizing edema fluid and initiate halting progression, at the least, or regression of fibrosclerotic tissue alterations. It also prevents reaccumulation of edema fluid and scar tissue breakdown. CDP is often complemented with diuretics. Limb sleeves or stockings and pneumatic pump devices are commonly employed for the treatment. In most severe cases, surgical debulking procedure may be required to alleviate the symptoms of lymphedema and to improve the quality of life. But patients have to be aided to live with the disease because an all-effective therapy is lacking.
METHODS
Thirty three lymphedema patients were studied prospectively in Department of Plastic Surgery, Raja Rajeswari Medical College and Hospital, Bangalore with prior approval of the institutional ethical committee. The aim of the research was to study lymphedema clinically and institute treatment accordingly and the outcome of same. Patient consent for the study was taken. Only patients with secondary lymphedema were included in the study.
All of these patients were referred to us from auxiliary departments at our institution and some presented directly. Complete medical evaluations to rule out other causes of swelling were done. Doppler venous scan to rule out deep venous thrombosis was done in suspected cases. Clinical proforma was designed for data collection. Clinical grading was done as per Brunner's as follows:
Grade 1 -oedema pits on pressure & largely disappears on elevation & bed rest II.
Grade 2 -oedema does not pit & does not significantly reduce on elevation III.
Grade 3 -oedema is associated with irreversible skin changes, i.e., fibrosis, papillae formation, hyperkerotosis.
In cases of extremity lymphedema, volume assessment was done by submerging each arm in a container filled with water, and measuring the volume displaced.
The therapy was individually tailored as per clinical requirement and patient's willingness for the treatment protocol. Patients were evaluated for the efficacy of the treatment initiated at 1, 3, 6 and 9 months with minimum follow-up of 9 months. Treatment methods included complex decongestive physiotherapy (CDP), pneumatic compression, use of elasto-compressive bandages, multilayered lymphedema bandages (MLLD) and limb elevation. CDP involved 2 phases -Phase 1 included 3 weeks of daily therapeutic sessions with manual lymph drainage, multilayered inelastic compression bandaging, and meticulous skin care by physiotherapist, followed by Phase 2 wherein the patient performed MLD oneself or with help of family members. Limb reduction surgery we employed for limb debulking was the Miller's procedure. Volumetric reductions before and after treatment initiation were assessed at regular intervals.
Statistical analysis was done using SPSS software. 
RESULTS
The results of our study are as follows.
Gender distribution
12 patients were males, 20 females and 1 was a third gender (Table 1) . 
Age distribution
Majority of the patient were in 3 rd to 6 th decade. The age of the treated patients ranged from 17 to 64 years (Table  2) . 
Region of the corpus involved
11 patients had upper-extremity lymphedema, 21 patients had lower-extremity lymphedema and 1 patient had lymphedema of the genitals (Table 3 ). 
Previous treatment history
15 patients had previously undergone treatment using pneumatic pumps and elastic garments before presenting in our department. These patients were not satisfied with treatment outcome obtained from previous physicians.
Lymphedema etiology
Lymphedema in 11 patients with malignancy was due to disease, post-surgical and post-radiotherapy. Post modified radical mastectomy, 7 patients and post radiotherapy 4 female patients had lymphedema. Lymphedema due to parasite (Filaria) and fungal infections was seen in 10 patients. Patients with prior fungal infections were being treated by dermatologists. Trauma as the cause for lymphedema was noted in 4 patients. Excluding other causes of lymphedema, obesity was found to be etiology in 3 patients. The BMI of all these were >34. There were 4 cases of lymphedema in patients who had undergone inguinal block dissection. One patient had lymphedema post varicose vein surgery (Table 4) . 
Patient complaints
Patient complaints ranged widely. Features included chronic swelling of the affected part, discomfort, lymphorrhea, reduced quality of life, social stigma, loss of employment and psychological trauma including distress, depression and suicidal tendencies. Stage 3 patients were the worst affected with patients having psychological trauma. 
Treatment
All patients underwent auxiliary treatment with elastic hosiery, limb elevation and skin care. Exercises were inculcated in the treatment appropriately based on patient compliance. Diuretics were used in 4 patients. 17 patients needed psychological support from Psychiatric consultation. Weight loss regime was also instituted in patients with obesity as the cause of lymphedema.
3 patients on pneumatic compression were shifted to CDP during treatment course and 4 patients initially on CDP underwent debulking surgery. One patient with scrotal lymphedema underwent debulking procedure (Table 6 ). 
Treatment outcome
Two patients were lost for follow-up during the course of this study. Both these patients had Stage 3 lower limb lymphedema and were on CDP. These patients were not satisfactory with the treatment outcome from start. One upper extremity patient with post mastectomy and radiotherapy lymphedema expired at 7 th month of study due to disseminated metastasis. Along with subjective assessment, volumetric assessment of the extremity was done based on fluid displacement. Based on both parameters treatment protocols were adequately changed accordingly (Table 7) . 
DISCUSSION
Lymphedema is a chronic oedema with devastating implications. It is a poorly recognized problem by health professionals and lymphedema due to non-cancer treatment are more prevalent than generally acknowledged. Although rarely lethal, lymphedema is a disfiguring and disabling condition with an associated decrease in the quality of life. Though the etiological factors for lymphedema have been identified there is lack of clarity in preventative strategies. Lymphoedema can occur at any age. The gender difference, as in many studies, cannot be explained purely by arm oedema related to breast cancer. 6 Acute complications of lymphoedema will cause disruptions to daily life, and significant deficits in quality of life. Also the emotional consequence of lymphedema has to be addressed. Also the disease affected their ability to work.
Advantages associated with MLD have been reported but yet, methodological inconsistencies between studies persist and conflicting reports of the effectiveness of MLD confound problem. 7, 8 Surgical treatment does not obviate the need for continued medical therapy. Surgical intervention is needed in cases who do not improve with conservative measures. Initial reductions in volume achieved are maintained in the majority of the treated patients by conservative measures.
Recent impressive expansion of knowledge in molecular mechanisms of lymphangiogenesis provides new possibilities for treatment of lymphedema. Lymphangiogenesis can be stimulated by various cytokines, such as vascular endothelial growth factors (VEGF) C and D which in turn activate the VEGF receptor-3 (VEGFR-3).
9,10 Also angiopoietin-1 has been found to promote lymphatic vessel formation and that fibroblast growth factor 2 stimulates lymphatic vessels growth. 11 Therefore, given the limitations in our knowledge and the important implications for patient care and quality of life, additional research is clearly required. However with the current treatment approach, results of treatment depend on the experience of the physician in clinical lymphology, on the training and dedication of the lymphedema physiotherapist and nevertheless on patient compliance.
CONCLUSION
Lymphedema is a debilitating disease with both physical and mental implications on the patient. The management should involve the patient too. The psychological aspect of the patient should also be addressed. Treatment should be tailored and changes be made appropriately as per requirement. With no current definitive therapy, a holistic approach is to be employed.
